Insider · CIK 0001838041
Ingmar Bruns
Files at ZNTL (Zentalis Pharmaceuticals, Inc.). First filing Feb 12, 2025, latest Feb 10, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZNTL: Zentalis Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Zentalis Pharmaceuticals, Inc. | $7,998 3,297 shares | -9% | +130% from low-36% from high | |
| 39Weak | Zentalis Pharmaceuticals, Inc. | $46k 20,000 shares | +120% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +9,727 | $2.18 | $21k | 43,059 | 11 d ago |
| Feb 6, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,962 | $2.43 | $7,197 | 33,667 | Feb 10, 2026 |
| Feb 9, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -335 | $2.39 | $802 | 33,332 | Feb 10, 2026 |
| Jan 8, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +365,000 | $0.00 | $0 | 365,000 | Jan 9, 2026 |
| Feb 6, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +20,000 | $2.28 | $46k | 36,629 | Feb 12, 2025 |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +16,629 | $0.00 | $0 | 16,629 | Feb 5, 2025 |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,629 | $0.00 | $0 | 16,629 | Feb 5, 2025 |
| Dec 2, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +712,650 | $0.00 | $0 | 712,650 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.